Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
Status:
Recruiting
Trial end date:
2024-12-24
Target enrollment:
Participant gender:
Summary
The purpose of the study is to the evaluate safety, tolerability, pharmacokinetics (PK), and
efficacy of AZD0466 as monotherapy in partciapants with advanced haematological malignancies
and also to assess drug-drug interaction (DDI) potential between AZD0466 and the azole
antifungal voriconazole.